Keymed Biosciences Co.Ltd
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS23
PHASE 3 / 2-35
RECRUITING11
READOUTS ≤12 MONTHS8
READOUT SLIPPED >6 MO11%
Delay Index: of 18 active trials registered more than a year ago, 2 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →
Open Keymed Biosciences Co.Ltd on the live radar map →| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| CM313 injection NCT06594146 |
P2 | Active, not recruiting | Primary Immune Thrombocytopenia | 62 | 2025-12-30 |
| Stapokibatrt NCT06956196 |
P3 | Not yet recruiting | Atopic Dermatitis | 240 | 2026-05 |
| CM336 Injection(Low dose group) NCT07039578 |
P2 | Recruiting | Primary Light-Chain Amyloidosis | 90 | 2026-06-30 |
| CM512 NCT06947980 |
P2 | Recruiting | Atopic Dermatitis | 200 | 2026-07-18 (+4 mo) |
| CM310 NCT06495229 |
P3 | Active, not recruiting | Atopic Dermatitis | 180 | 2026-08-30 |
| CM313 injection NCT06791772 |
P2 | Not yet recruiting | Systemic Lupus Erythematosus | 150 | 2026-10 |
| CM512 injection NCT07166211 |
P2 | Recruiting | Chronic Spontaneous Urticaria (CSU) | 48 | 2026-11-02 |
| CM336_group 1 NCT05299424 |
P1/2 | Recruiting | Multiple Myeloma | 48 | 2026-12 |
| Stapokibatrt NCT07106372 |
P3 | Not yet recruiting | Atopic Dermatitis | 240 | 2027-02 |
| CM313 NCT06830395 |
P2 | Not yet recruiting | IgA Nephropathy | 106 | 2027-03 (+11 mo) |
| CM350 group1 NCT05263960 |
P1/2 | Recruiting | Advanced Solid Tumor | 248 | 2027-04 (+25 mo) |
| CM338 NCT05775042 |
P2 | Recruiting | IgA Nephropathy | 70 | 2027-06-30 |
| CM512 injection NCT07011524 |
P2 | Recruiting | Asthma | 200 | 2027-07-21 |
| CM336 Injection NCT07181239 |
P3 | Not yet recruiting | Multiple Myeloma (MM) | 280 | 2027-09 |
| CM313(SC) injection-low dose NCT06792019 |
P1/2 | Recruiting | Platelet Transfusion Refractoriness | 110 | 2027-11-16 (+6 mo) |
| CM336 Injection NCT07175493 |
P1/2 | Recruiting | Autoimmune Cytopenia; Immune Thrombocytopenia (ITP) | 158 | 2027-11-18 |
| CM313(SC) injection NCT06791824 |
P1/2 | Not yet recruiting | Aplastic Anemia | 125 | 2027-12 |
| CM512 NCT07230483 |
P2 | Recruiting | Atopic Dermatitis (AD) | 246 | 2027-12 |
| CM512 NCT06980142 |
P2 | Not yet recruiting | Chronic Obstructive Pulmonary Disease | 204 | 2028-03-17 |
| CM512 NCT07519577 |
P2 | Not yet recruiting | Chronic Rhinosinusitis With Nasal Polyposis | 120 | 2028-05-31 |
| CM518D1 NCT07019779 |
P1/2 | Recruiting | Advanced Solid Tumors | 434 | 2028-12-31 |
| CM529D1 NCT07893171 |
P1/2 | Not yet recruiting | Advanced Solid Tumors | 128 | 2029-12-31 |
| CM336 NCT07910903 |
P3 | Not yet recruiting | Multiple Myeloma (MM) | 320 | 2030-05 |